21-29036368-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006447.3(USP16):āc.442A>Cā(p.Lys148Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,613,532 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006447.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USP16 | NM_006447.3 | c.442A>C | p.Lys148Gln | missense_variant | 5/18 | ENST00000399976.7 | NP_006438.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USP16 | ENST00000399976.7 | c.442A>C | p.Lys148Gln | missense_variant | 5/18 | 1 | NM_006447.3 | ENSP00000382858 | P5 | |
USP16 | ENST00000399975.7 | c.442A>C | p.Lys148Gln | missense_variant | 5/18 | 1 | ENSP00000382857 | A1 | ||
USP16 | ENST00000474835.5 | n.610A>C | non_coding_transcript_exon_variant | 5/17 | 1 | |||||
USP16 | ENST00000334352.8 | c.442A>C | p.Lys148Gln | missense_variant | 6/19 | 5 | ENSP00000334808 | P5 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000439 AC: 11AN: 250828Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135558
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461198Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 726908
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152334Hom.: 0 Cov.: 32 AF XY: 0.0000805 AC XY: 6AN XY: 74494
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 17, 2024 | The c.442A>C (p.K148Q) alteration is located in exon 6 (coding exon 4) of the USP16 gene. This alteration results from a A to C substitution at nucleotide position 442, causing the lysine (K) at amino acid position 148 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at